SCHEMBL30306644

SCHEMBL30306644

CN(C(=O)CCCCCNC(=O)NCc1ccc(Cl)cc1)c1cccnc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT4 P35916 2/20 0.55
▸ FES P07332 1/20 0.55
▸ RET P07949 1/20 0.55
▸ MARK3 P27448 1/20 0.55
▸ TYK2 P29597 1/20 0.55
▸ SYK P43405 1/20 0.55
▸ CLK2 P49760 1/20 0.55
▸ CLK4 Q9HAZ1 1/20 0.55
▸ HDAC3 O15379 4/20 0.48
▸ HDAC4 P56524 4/20 0.48
▸ HDAC1 Q13547 4/20 0.48
▸ HDAC7 Q8WUI4 4/20 0.48
▸ HDAC2 Q92769 4/20 0.48
▸ HDAC10 Q969S8 4/20 0.48
▸ HDAC11 Q96DB2 4/20 0.48
▸ HDAC8 Q9BY41 4/20 0.48
▸ HDAC6 Q9UBN7 4/20 0.48
▸ HDAC9 Q9UKV0 4/20 0.48
▸ HDAC5 Q9UQL6 4/20 0.48
▸ TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011594 1.00 FLT4 (0.55) FLT4FESRETMARK3TYK2
SCHEMBL24011406 0.88 HDAC1 (0.52) FLT4FESRETMARK3TYK2
SCHEMBL24011597 0.87 PPIB (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL24011407 0.83 HDAC1 (0.49) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL30306652 0.83 HDAC1 (0.49) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL30306667 0.81 HDAC6 (0.47) FLT4FESRETMARK3TYK2
SCHEMBL24011098 0.81 HDAC6 (0.47) FLT4FESRETMARK3TYK2
SCHEMBL24011408 0.78 HDAC1 (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL24011671 0.78 TSHR (0.75) FLT4FESRETMARK3TYK2
SCHEMBL30634149 0.78 TSHR (0.75) FLT4FESRETMARK3TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115843295-B NAMPT modulators 赛特凯恩蒂克公司 2025-04-15 — — CN disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
CN-115843295-A NAMPT modulators 赛特凯恩蒂克公司 2023-03-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT FLT4 3459/4885FES 3568/4885RET 2361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback